Cbd Pro+Care
Pharmaceutical Manufacturing • 
Manhattan, New York, United States • 1-10 Employees
Company overview
| Headquarters | 42 Broadway, New York, NY 10006, US |
| Website | |
| NAICS | 3254 |
| SIC | 722 |
| Keywords | Health, Pharmaceuticals, CBD |
| Founded | 2018 |
| Employees | 1-10 |
Key Contact at Cbd Pro+Care
John Cook
Chief Executive Officer
About Cbd Pro+Care
CBD PRO+CARE specializes in manufacturing and developing CELLg8™ Liposomal which is a nutrient delivery system that has been clinically proven through safety, absorption, and blood glucose studies to enhance the absorption of CBD. The stomach will vaporize more CBD than it absorbs. While traditional CBD supplements hold many health benefits, the majority of their active compounds are destroyed during digestion, so that’s where CELLg8™ Liposomal comes in. CELLg8™ Liposomal technology has become the Infinite Solution, delivering maximum nutrient absorption throughout the body. This is a new era in consuming CBD.
Cbd Pro+Care revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Cbd Pro+Care has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Cbd Pro+Care has never raised funding before.
Cbd Pro+Care Tech Stack
Discover the technologies and tools that power Cbd Pro+Care's digital infrastructure, from frameworks to analytics platforms.
Hosting
Reverse proxies
Font scripts
United Kingdom
Germany
Australia
Frequently asked questions
4.8
40,000 users
